Fundraising FoxShangBay Capital LLC — 2014 Investments
1 investments dated 2014 · listed companies and verified rows first · show all
Tvardi Therapeuticstvarditherapeutics.comin𝕏NASDAQ: TVRDDec 2014
Tvardi Therapeutics is a clinical-stage biopharmaceutical company developing oral small molecule STAT3 inhibitors to treat inflammatory and proliferative diseases.
BiotechHealthtechHouston, US
David J. Tweardy(Executive Officer, Director)Josef Schoell(Executive Officer)inJoseph W. Stauffer(Executive Officer)Derek Chalmers(Executive Officer, Director)inMichael E. Lewis(Executive Officer)inFrederique Menzaghi(Executive Officer)
Co-investorsSolas BioVentures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.